GlobeNewswire Inc.··The Gross Law FirmATRA Faces Securities Class Action Over FDA Drug Approval Setbacks
Shareholders sue Atara Biotherapeutics for allegedly misleading statements on manufacturing issues and failed ALLELE study data affecting tabelecleucel approval prospects.
ATRAshareholder lawsuitsecurities class action